{"id":53865,"date":"2025-10-15T08:00:00","date_gmt":"2025-10-15T06:00:00","guid":{"rendered":"https:\/\/www.stille.se\/us\/mfn_news\/stille-ab-announces-new-executive-management-and-group-structure\/"},"modified":"2025-10-15T08:00:00","modified_gmt":"2025-10-15T06:00:00","slug":"stille-ab-announces-new-executive-management-and-group-structure","status":"publish","type":"mfn_news","link":"https:\/\/www.stille.se\/us\/news\/stille-ab-announces-new-executive-management-and-group-structure\/","title":{"rendered":"Stille AB announces new Executive Management and group structure"},"content":{"rendered":"
\n

Stille AB (publ) announces new Executive Management team, with the appointment of Niklas Tyr\u00e9n as Group CFO and Martin Richardson as Group COO.<\/strong><\/p>\n<\/div>\n

\n

Stille AB today announces a new Executive Management and group structure to support the company\u2019s continued international growth. The new organization strengthens group capabilities in Finance, Operations and QA\/RA.<\/p>\n

We are announcing the appointment of two members of Executive Management: Niklas Tyr\u00e9n will join as Group CFO on December 8th, 2025, and Martin Richardson will join as Group COO no later than January 2nd, 2026. These appointments mark an exciting new chapter for Stille, as the company continues to expand its global presence and enhance operational performance.<\/p>\n

Niklas Tyr\u00e9n is an experienced CFO with more than 25 years in publicly listed, private equity\u2013owned, and family-held companies across MedTech, FMCG, and retail. As Group CFO of Kjell & Company, he played a central role in transforming the business from a Nordic specialty retailer into a listed group. Earlier in his career, he held senior finance positions at Findus, Heinz Nordic, Gambro and Unilever, developing strong expertise in strategic planning, business transformation, and international operations.<\/p>\n

\u201cI am honoured to join Stille as CFO. It is an exciting company with a tremendous potential, and I look forward to driving the growth together with the rest of the organization over the coming years\u201d, says Niklas Tyr\u00e9n.<\/p>\n

Martin Richardson is an experienced operations leader with more than 20 years in international manufacturing and supply chain management across MedTech and life sciences. As Vice President International Manufacturing at Coloplast, Martin has been responsible for production sites in China, Germany, and Sweden. Earlier in his career, he held senior roles at Atos Medical, Baxter and Gambro, developing deep expertise in operational excellence, global supply chain leadership, QA\/RA and large-scale transformation.<\/p>\n

\u201cI am excited to join Stille as COO and lead the development of our global operations and supply chain. Stille has an incredible portfolio of products, and I look forward to working with the rest of the team to ensure that we scale our operations and supply chain to meet the high demand in the coming years\u201d, says Martin Richardson.<\/p>\n

"I am thrilled to welcome Niklas and Martin to Stille," says Ulrik Berthelsen CEO of Stille AB. "We are adding two senior leaders with deep finance and operations experience to the Executive team, and they will play an instrumental role in driving the next phase of our growth and development as a group."<\/p>\n

Executive Management will, in the future, consist of CEO Ulrik Berthelsen, CFO Niklas Tyr\u00e9n and COO Martin Richardson. The local CEOs of Stille Inc, S&T, Fehling and Surgical Holdings continue as part of the Leadership Team.<\/p>\n

\u201cBy combining local ownership and entrepreneurship with stronger group capabilities, we are building a scalable organization that can support both organic growth and future acquisitions.\u201d says Ulrik Berthelsen, CEO of Stille AB.<\/p>\n<\/div>\n

\n

This information is information that Stille is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-10-15 08:00 CEST.<\/em><\/p>\n<\/div>\n

\n

Contact Details<\/strong>
Ulrik Berthelsen<\/strong>
CEO & President
+46 (0)73 033 38 25 | ulrik.berthelsen@stille.se<\/p>\n<\/div>\n

\n

About Us<\/strong>
Stille AB (publ) is a well-established pioneer in the development, manufacturing and distribution<\/strong> of premium surgical instruments and advanced surgical tables, with a differentiated offering in fast growing niche markets for high-precision procedures. Stille was founded in 1841 and is listed on Nasdaq First North Growth Market under the ticker \u201cSTIL\u201d with Eminova AB as Certified Adviser, Eminova Fondkommission AB, +46 8 684 211 10, adviser@eminova.se. More information is available at www.stille.se<\/a>.<\/p>\n<\/div>\n

\n

Attachments<\/strong>
Stille AB announces new Executive Management and group structure<\/a><\/p>\n<\/div>\n